Dublin, Ireland – October 27, 2020 – Perrigo Company plc (NYSE; TASE: PRGO), the leading provider of Quality, Affordable Self-Care Products, announced today that it is building a new North American Corporate Headquarters in the heart of Grand Rapids, Michigan. The new headquarters will augment Perrigo’s existing presence in West Michigan, which was established in 1887 and now includes extensive operations in Allegan, Holland and Grand Rapids.
Perrigo’s new offices will be constructed in Michigan State University’s (MSU) expanding Grand Rapids Innovation Park, a public-private partnership that is bringing together academic medicine, healthcare delivery and other partners interested in the transformation of health. The location places Perrigo, the world’s leading over-the-counter health and wellness organization, in the company of academic, research and clinical experts found within the medical park network.
DUBLIN, Sept. 17, 2020-- Perrigo Company plc (NYSE; TASE: PRGO) today announced a voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol to the retail level after previously halting production and distribution. These actions are being taken out of an abundance of caution as a result of complaints that some units may not dispense due to clogging. Perrigo's generic albuterol sulfate inhalation aerosol was developed in partnership with and manufactured by Catalent Pharma Solutions.
DUBLIN, Sept. 8, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has launched the store brand equivalent of over-the-counter ("OTC") Voltaren® Arthritis Pain (diclofenac sodium topical gel, 1%) to its retail partners and the product is now available in the U.S. nationwide. Perrigo's abbreviated new drug application ("ANDA") for OTC diclofenac sodium topical gel, 1% is the first store brand ANDA to receive approval from the U.S. Food and Drug Administration.
DUBLIN, Aug. 11, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that it will acquire three Eastern European OTC skincare and hair loss treatment brands (Emolium®, Iwostin® and Loxon®) from Sanofi. Trailing twelve months net sales ending June 30, 2020 for these products were approximately €21 million or approximately $23 million*. Other terms of the transaction were not disclose
DUBLIN, June 19, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has reached a definitive agreement to sell its U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for £156 million or approximately $195 million in cash. This transaction, which was signed and closed on the same day, represents another step in Perrigo's transformation to a consumer-focused self-care company.
DUBLIN, June 17, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, announced today that it is entering the cannabidiol ("CBD") market through a strategic investment in and long-term supply agreement with Kazmira LLC, a leading supplier of hemp-based CBD products free of tetrahydrocannabinol ("THC-free") based in Watkins, Colorado. The fast-growing and rapidly evolving CBD market is emerging organically in response to changing consumer preferences for natural remedies and aligns with Perrigo's vision "To make lives better by bringing quality, affordable self-care products that consumers trust everywhere they are sold."
Perrigo is one of 36 companies and individuals named as defendants in the most recent complaint filed by various state attorneys general in relation to alleged antitrust violations within the generic pharmaceutical industry.
A year ago, we launched a new Diversity and Inclusion initiative for Perrigo that stressed the importance of having all members of our community treated with fairness and respect.
Allegan, Michigan and Bronx, New York – April 14, 2020 – Perrigo Company plc is responding to the urgent needs of hospital, medical and first responder personnel who are running dangerously low on medical supplies. Over the next few months, the Company will donate at least 500,000 bottles of hand sanitizer to local hospitals and first responders facing urgent shortages of this essential product.
DUBLIN, Ireland and Allegan, Michigan – April 7, 2020 – Perrigo Company plc and the Perrigo Company Charitable Foundation are donating $400,000 in funding and $216,000 in product donations to assist community partners who are essential to the COVID-19 response effort. Perrigo acted quickly to address the urgent need.